Gene Amplification Technologies Market Is Likely to Experience a Tremendous Growth in Near Future

Gene Amplification Technologies Industry Overview

The global gene amplification technologies market size is expected to reach USD 30.80 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.0% from 2021 to 2028. The major factors driving the market are the expanding research in molecular diagnostics and genomics, the introduction of novel and advanced products, and the growing acceptance of personalized medicine.

 

Gene Amplification Technologies Market Segmentation

Grand View Research has segmented the global gene amplification technologies market on the basis of technology, downstream application, sample type, product, end use, and region:

 

Based on the Technology Insights, the market is segmented into PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification, and Others

• The Polymerase Chain Reaction (PCR)-based amplification segment accounted for the largest revenue share of over 85.0% in 2020. This can be attributed to the widespread use of PCR technology across various end-use applications.
• However, several technological challenges associated with the use of PCR technology have spurred the development and usage of substitute technologies such as Loop-Mediated Isothermal Amplification (LAMP) and Multiple Displacement Amplification.

 

Based on the Downstream Application Insights, the market is segmented into Whole Genome Amplification, Exome Sequencing, SNP Genotyping Arrays, Array CGH, Hybridization, and Others

• The hybridization segment captured the largest revenue share of over 30.0% in 2020. Several multiplication technologies are increasingly being used in the hybridization process. In October 2020, researchers from Thailand developed a new method that enabled co-hybridization and amplification of targeted DNA in a single reaction.
• The new method – Probe-triggered, One-step, Simultaneous DNA Hybridization, and LAMP Integrated with LFD was found to be more sensitive and easy to perform as compared to other PCR and LAMP-LFD methods. Such advancements are expected to propel the segment growth throughout the forecast period.
• The exome sequencing segment held the second-largest revenue share in 2020 as this method is a cost-effective alternative to whole-genome sequencing. It offers the ability to use sequencing and analysis resources more efficiently to the research community.

 

Based on the Sample Type Insights, the market is segmented into Single Cell, FFPE, and Others

• In 2020, the others segment held the largest revenue share of over 45.0%. The single-cell segment accounted for the second-largest revenue share in 2020. This can be attributed to the wide availability of products for amplification using single-cell samples, coupled with the advantages offered by single-cell samples.
• The operating players such as QIAGEN NV, Merck KGaA (Sigma Aldrich), Cytiva, New England Biolabs, and Silicon Biosystemsfocus are focusing on the introduction of new products in this space to address the increasing demand for genomics studies.

 

Based on the Product Insights, the market is segmented into Instruments, Kits & Reagents, and Services

• The kits and reagents segment captured the largest revenue share of over 60.0% in 2020. The presence of a substantial number of companies offering various kits, media, and reagents, coupled with the growing demand for kits and reagents in molecular diagnostics and genomics research, is expected to fuel the segment growth throughout the forecast period.
• Owing to the widespread use of PCR-based amplification, a substantial number of companies offer PCR instruments. With the increasing application of gene amplification technologies, the market players are focusing on the introduction of new innovative products in this market space.

Based on the End-use Insights, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others

• The others segment comprising clinics, hospitals, and diagnostic laboratories accounted for the largest revenue share of over 40.0% in 2020 due to the ongoing pandemic management. Hospital laboratories, clinics, and diagnostic centers prefer the PCR technique over others, thereby driving the market.
• Furthermore, researchers from the University of Alberta and the University of Calgary are engaged in the development of point of care diagnostics based on isothermal amplification techniques for the detection of the COVID-19 virus. Such studies indicate the growing involvement of research and academic institutes in this market space.
• The growing penetration of gene multiplication techniques in pharmaceutical and biotechnology companies has resulted in significant revenue generation by this segment. These companies are focusing on the development of molecular diagnostic tests based on amplification methods, thereby fueling the market growth.

Gene Amplification Technologies Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

 

Key Companies Profile & Market Share Insights

The market is expected to witness remarkable growth in the coming years. The expanding product portfolio of operating players and an increasing number of technological collaborations between operating entities have intensified the market competition.

Some prominent players in the global gene amplification technologies market include:

• QIAGEN
• New England Biolabs
• Illumina Inc.
• Yikang Gene
• Bio-Rad Laboratories
• Silicon Biosystems
• Merck KGaA
• Promega Corporation
• Takara Bio Inc.
• Danaher Corporation
• 4basebio AG
• LGC Group
• Vazyme Biotech Co. Ltd.
• MyBioSource

 

Order a free sample PDF of the Gene Amplification Technologies Market Intelligence Study, published by Grand View Research.